Charles River Laboratories International (CRL) Deferred Taxes (2009 - 2026)

Charles River Laboratories International has reported Deferred Taxes for 18 years, with the latest figure at $41.5 million in Q2 2026.

• On a quarterly basis, Deferred Taxes rose 288.7% year-over-year to $41.5 million in Q2 2026; TTM through Jun 2026 was -$22.2 million, a 76.74% increase from a year earlier, with the FY2025 full-year figure at -$75.3 million, down 11.66% from the prior year.
• Deferred Taxes was $41.5 million for Q2 2026 at Charles River Laboratories International, up from -$29.4 million in the prior quarter.
• The five-year high for Deferred Taxes was $41.5 million in Q2 2026, with the low at -$60.2 million in Q4 2025.
• Average Deferred Taxes over 5 years is -$12.1 million, with a median of -$11.7 million recorded in 2022.
• The largest YoY upside for Deferred Taxes was 300.6% in 2025 against a maximum downside of 1829.18% in 2025.
• Over 5 years, Deferred Taxes stood at -$9.6 million in 2022, then sank by 136.92% to -$22.7 million in 2023, then sank by 82.94% to -$41.4 million in 2024, then plunged by 45.2% to -$60.2 million in 2025, then surged by 168.96% to $41.5 million in 2026.
• The last three Deferred Taxes figures came in at $41.5 million (Q2 2026), -$29.4 million (Q1 2026), and -$60.2 million (Q4 2025), per Business Quant data.